{"quoteSummary":{"result":[{"defaultKeyStatistics":{"maxAge":1,"priceHint":{"raw":2,"fmt":"2","longFmt":"2"},"enterpriseValue":{"raw":369360256,"fmt":"369.36M","longFmt":"369,360,256"},"forwardPE":{},"profitMargins":{"raw":0.0039399997,"fmt":"0.39%"},"floatShares":{"raw":7944149,"fmt":"7.94M","longFmt":"7,944,149"},"sharesOutstanding":{"raw":16210400,"fmt":"16.21M","longFmt":"16,210,400"},"sharesShort":{},"sharesShortPriorMonth":{},"heldPercentInsiders":{},"heldPercentInstitutions":{},"shortRatio":{},"shortPercentOfFloat":{},"beta":{"raw":0.303987,"fmt":"0.3"},"morningStarOverallRating":{},"morningStarRiskRating":{},"category":null,"bookValue":{"raw":3.806,"fmt":"3.81"},"priceToBook":{"raw":2.9873884,"fmt":"2.99"},"annualReportExpenseRatio":{},"ytdReturn":{},"beta3Year":{},"totalAssets":{},"yield":{},"fundFamily":null,"fundInceptionDate":{},"legalType":null,"threeYearAverageReturn":{},"fiveYearAverageReturn":{},"priceToSalesTrailing12Months":{},"lastFiscalYearEnd":{"raw":1490918400,"fmt":"2017-03-31"},"nextFiscalYearEnd":{"raw":1553990400,"fmt":"2019-03-31"},"mostRecentQuarter":{"raw":1514678400,"fmt":"2017-12-31"},"earningsQuarterlyGrowth":{},"revenueQuarterlyGrowth":{},"netIncomeToCommon":{"raw":1789000,"fmt":"1.79M","longFmt":"1,789,000"},"trailingEps":{"raw":0.118,"fmt":"0.12"},"forwardEps":{},"pegRatio":{},"lastSplitFactor":"1/10","lastSplitDate":{"raw":1418342400,"fmt":"2014-12-12"},"enterpriseToRevenue":{"raw":0.813,"fmt":"0.81"},"enterpriseToEbitda":{"raw":22.131,"fmt":"22.13"},"52WeekChange":{"raw":0.11077535,"fmt":"11.08%"},"SandP52WeekChange":{"raw":0.12668931,"fmt":"12.67%"},"lastDividendValue":{},"lastCapGain":{},"annualHoldingsTurnover":{}},"summaryProfile":{"address1":"SCO 825, Shivalik Enclave","address2":"1st Floor NAC Manimajra","city":"Chandigarh","zip":"160101","country":"India","website":"http://www.syschem.in","industry":"Drug Manufacturers - Major","sector":"Healthcare","longBusinessSummary":"Syschem (India) Limited manufactures and sells bulk drugs and intermediates, specialty chemicals, and solvents in India. The company's products include methanol; and APIs/intermediates, such as amoxycillin tri hydrate, ampicillin tri hydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, oxacillin, and cephalexin, as well as DMF, acetonitrile, ethyl acetate, and THF. It is also involved in the contract manufacturing and custom synthesis activities; and purification of specialty solvents. Syschem (India) Limited was incorporated in 1993 and is based in Chandigarh, India.","fullTimeEmployees":5,"companyOfficers":[],"maxAge":86400},"financialData":{"maxAge":86400,"currentPrice":{"raw":11.37,"fmt":"11.37"},"targetHighPrice":{},"targetLowPrice":{},"targetMeanPrice":{},"targetMedianPrice":{},"recommendationMean":{},"recommendationKey":"none","numberOfAnalystOpinions":{},"totalCash":{"raw":2996000,"fmt":"3M","longFmt":"2,996,000"},"totalCashPerShare":{"raw":0.211,"fmt":"0.21"},"ebitda":{"raw":16690000,"fmt":"16.69M","longFmt":"16,690,000"},"totalDebt":{"raw":201255008,"fmt":"201.26M","longFmt":"201,255,008"},"quickRatio":{},"currentRatio":{},"totalRevenue":{"raw":454272992,"fmt":"454.27M","longFmt":"454,272,992"},"debtToEquity":{"raw":307.546,"fmt":"307.55"},"revenuePerShare":{"raw":31.138,"fmt":"31.14"},"returnOnAssets":{},"returnOnEquity":{},"grossProfits":{"raw":14308000,"fmt":"14.31M","longFmt":"14,308,000"},"freeCashflow":{},"operatingCashflow":{},"earningsGrowth":{},"revenueGrowth":{"raw":123.829,"fmt":"12,382.90%"},"grossMargins":{"raw":0.17026,"fmt":"17.03%"},"ebitdaMargins":{"raw":0.03674,"fmt":"3.67%"},"operatingMargins":{"raw":-0.0066500003,"fmt":"-0.67%"},"profitMargins":{"raw":0.0039399997,"fmt":"0.39%"},"financialCurrency":"INR"}}],"error":null}}